SPECIFICITIES OF THE SUBSET PROFILE OF PERIPHERAL BLOOD IN PATIENTS WITH GLIOBLASTOMA: PATHOGENETIC AND CLINICAL ASSESSMENTS
Abstract. In glioblastoma (GB), it is necessary to take into consideration GB-associated secondary immunodeficiency (SID), so-called syndrome of tumor-associated SID (STASID). Cell subsets having effector and regulatory functions, play an important role in developing STASID, and their proportions in...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2014-07-01
|
| Series: | Медицинская иммунология |
| Subjects: | |
| Online Access: | https://www.mimmun.ru/mimmun/article/view/424 |
| _version_ | 1797198065579327488 |
|---|---|
| author | V. A. Chumakov O. A. Pronina I. A. Kachkov A. G. Korshounov B. V. Pineguin I. I. Anan’eva T. Elbeik L. S. Metelitsa A. E. Dorofeev N. V. Gnouchev S. V. Souchkov |
| author_facet | V. A. Chumakov O. A. Pronina I. A. Kachkov A. G. Korshounov B. V. Pineguin I. I. Anan’eva T. Elbeik L. S. Metelitsa A. E. Dorofeev N. V. Gnouchev S. V. Souchkov |
| author_sort | V. A. Chumakov |
| collection | DOAJ |
| description | Abstract. In glioblastoma (GB), it is necessary to take into consideration GB-associated secondary immunodeficiency (SID), so-called syndrome of tumor-associated SID (STASID). Cell subsets having effector and regulatory functions, play an important role in developing STASID, and their proportions in patients with different forms of GB can be of pathogenetic importance and have clinical value for treatment and rehabilitation scheduling as well. The most pathogenically and clinically important features of cell subsets profile of peripheral blood were analyzed in patients with different clinical and morphological types of GB. The patients were divided into three groups, i.e., groups I and II were formed by patients with STASID (marked and slightly marked SID, accordingly); group III – patients with SIDTAS (tumor-associated autoimmune syndrome, associated with SID). Marked suppression of cell immunity is typical of group I - imbalance in T-lymphocytes, in a number of specific subsets, and in subsets clusters, as well as disproportions in the immunoregulatory indexes. In group II, the subset profiles of blood were slightly different from the norm. In patients with SIDTAS, activation of cell immunity was evident, forming SID with signs of autoimmune syndrome, affecting effector and regulatory chains of immunity, and influencing the severity and forecast of the disease. Specific features of the immune status in patients with GB identified can be resulted from different clinicalmorphological types of the tumor; the latter are to be considered in differential diagnostics of clinical course of GB and in scheduling of clinical-immunological efficient anti-tumor pharmacotherapy in pre- and postoperative periods. |
| first_indexed | 2024-03-08T05:51:18Z |
| format | Article |
| id | doaj.art-0d85015c494a4ec09bab63f483d9478f |
| institution | Directory Open Access Journal |
| issn | 1563-0625 2313-741X |
| language | Russian |
| last_indexed | 2024-04-24T06:53:56Z |
| publishDate | 2014-07-01 |
| publisher | St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists |
| record_format | Article |
| series | Медицинская иммунология |
| spelling | doaj.art-0d85015c494a4ec09bab63f483d9478f2024-04-22T13:07:36ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2014-07-0181375010.15789/1563-0625-2006-1-37-50421SPECIFICITIES OF THE SUBSET PROFILE OF PERIPHERAL BLOOD IN PATIENTS WITH GLIOBLASTOMA: PATHOGENETIC AND CLINICAL ASSESSMENTSV. A. Chumakov0O. A. Pronina1I. A. Kachkov2A. G. Korshounov3B. V. Pineguin4I. I. Anan’eva5T. Elbeik6L. S. Metelitsa7A. E. Dorofeev8N. V. Gnouchev9S. V. Souchkov10МОНИКИ им. М.Ф. Владимирского, МоскваМОНИКИ им. М.Ф. Владимирского, МоскваМОНИКИ им. М.Ф. Владимирского, МоскваИнститут нейрохирургии им. Н.Н. Бурденко РАМН, МоскваГНЦ “Институт иммунологии”, МоскваМОНИКИ им. М.Ф. Владимирского, МоскваSchool of Medicine, UCSF, S F, CAUniversity of Southern California, LA, CAПавлово-Посадская ЦРБ Московской областиИнститут биологии гена РАН, МоскваМОНИКИ им. М.Ф. Владимирского; ММА им. И.М. Сеченова, МоскваAbstract. In glioblastoma (GB), it is necessary to take into consideration GB-associated secondary immunodeficiency (SID), so-called syndrome of tumor-associated SID (STASID). Cell subsets having effector and regulatory functions, play an important role in developing STASID, and their proportions in patients with different forms of GB can be of pathogenetic importance and have clinical value for treatment and rehabilitation scheduling as well. The most pathogenically and clinically important features of cell subsets profile of peripheral blood were analyzed in patients with different clinical and morphological types of GB. The patients were divided into three groups, i.e., groups I and II were formed by patients with STASID (marked and slightly marked SID, accordingly); group III – patients with SIDTAS (tumor-associated autoimmune syndrome, associated with SID). Marked suppression of cell immunity is typical of group I - imbalance in T-lymphocytes, in a number of specific subsets, and in subsets clusters, as well as disproportions in the immunoregulatory indexes. In group II, the subset profiles of blood were slightly different from the norm. In patients with SIDTAS, activation of cell immunity was evident, forming SID with signs of autoimmune syndrome, affecting effector and regulatory chains of immunity, and influencing the severity and forecast of the disease. Specific features of the immune status in patients with GB identified can be resulted from different clinicalmorphological types of the tumor; the latter are to be considered in differential diagnostics of clinical course of GB and in scheduling of clinical-immunological efficient anti-tumor pharmacotherapy in pre- and postoperative periods.https://www.mimmun.ru/mimmun/article/view/424glioblastomasecondary immunodeficiencyautoimmune syndromelympholytes subpopulationsanti-tumor immunity |
| spellingShingle | V. A. Chumakov O. A. Pronina I. A. Kachkov A. G. Korshounov B. V. Pineguin I. I. Anan’eva T. Elbeik L. S. Metelitsa A. E. Dorofeev N. V. Gnouchev S. V. Souchkov SPECIFICITIES OF THE SUBSET PROFILE OF PERIPHERAL BLOOD IN PATIENTS WITH GLIOBLASTOMA: PATHOGENETIC AND CLINICAL ASSESSMENTS Медицинская иммунология glioblastoma secondary immunodeficiency autoimmune syndrome lympholytes subpopulations anti-tumor immunity |
| title | SPECIFICITIES OF THE SUBSET PROFILE OF PERIPHERAL BLOOD IN PATIENTS WITH GLIOBLASTOMA: PATHOGENETIC AND CLINICAL ASSESSMENTS |
| title_full | SPECIFICITIES OF THE SUBSET PROFILE OF PERIPHERAL BLOOD IN PATIENTS WITH GLIOBLASTOMA: PATHOGENETIC AND CLINICAL ASSESSMENTS |
| title_fullStr | SPECIFICITIES OF THE SUBSET PROFILE OF PERIPHERAL BLOOD IN PATIENTS WITH GLIOBLASTOMA: PATHOGENETIC AND CLINICAL ASSESSMENTS |
| title_full_unstemmed | SPECIFICITIES OF THE SUBSET PROFILE OF PERIPHERAL BLOOD IN PATIENTS WITH GLIOBLASTOMA: PATHOGENETIC AND CLINICAL ASSESSMENTS |
| title_short | SPECIFICITIES OF THE SUBSET PROFILE OF PERIPHERAL BLOOD IN PATIENTS WITH GLIOBLASTOMA: PATHOGENETIC AND CLINICAL ASSESSMENTS |
| title_sort | specificities of the subset profile of peripheral blood in patients with glioblastoma pathogenetic and clinical assessments |
| topic | glioblastoma secondary immunodeficiency autoimmune syndrome lympholytes subpopulations anti-tumor immunity |
| url | https://www.mimmun.ru/mimmun/article/view/424 |
| work_keys_str_mv | AT vachumakov specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments AT oapronina specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments AT iakachkov specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments AT agkorshounov specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments AT bvpineguin specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments AT iiananeva specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments AT telbeik specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments AT lsmetelitsa specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments AT aedorofeev specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments AT nvgnouchev specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments AT svsouchkov specificitiesofthesubsetprofileofperipheralbloodinpatientswithglioblastomapathogeneticandclinicalassessments |